Igor Bado

1.8k total citations · 1 hit paper
16 papers, 690 citations indexed

About

Igor Bado is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Igor Bado has authored 16 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Igor Bado's work include Bone health and treatments (5 papers), Cancer-related Molecular Pathways (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Igor Bado is often cited by papers focused on Bone health and treatments (5 papers), Cancer-related Molecular Pathways (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Igor Bado collaborates with scholars based in United States, Sweden and Israel. Igor Bado's co-authors include Xiang H.-F. Zhang, Weijie Zhang, Hai Wang, Yang Gao, Jeffrey M. Rosen, Christoforos Thomas, Fotis Nikolos, Jan-Ακε Gustafsson, Zbigniew Gugala and Suzanne A.W. Fuqua and has published in prestigious journals such as Cancer Cell, Oncogene and Developmental Cell.

In The Last Decade

Igor Bado

16 papers receiving 684 citations

Hit Papers

Metastasis Organotropism: Redefining the Congenial Soil 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Bado United States 13 388 331 184 119 83 16 690
Thomas Kryza Australia 16 268 0.7× 256 0.8× 160 0.9× 116 1.0× 37 0.4× 33 657
Gvantsa Kharaishvili Czechia 18 347 0.9× 404 1.2× 221 1.2× 153 1.3× 34 0.4× 26 776
Fabiana Lüönd Switzerland 7 330 0.9× 380 1.1× 237 1.3× 95 0.8× 29 0.3× 9 683
Jesús Anampa United States 7 415 1.1× 242 0.7× 230 1.3× 121 1.0× 36 0.4× 14 746
Satoko Yamamoto Japan 18 213 0.5× 301 0.9× 148 0.8× 86 0.7× 58 0.7× 35 648
Sujatha Jagadeeswaran United States 12 360 0.9× 465 1.4× 197 1.1× 169 1.4× 48 0.6× 16 973
Manjiri M. Bakre India 14 199 0.5× 515 1.6× 205 1.1× 71 0.6× 82 1.0× 32 822
Johannes Betge Germany 16 706 1.8× 496 1.5× 210 1.1× 238 2.0× 89 1.1× 43 1.2k
Shany Koren Switzerland 8 320 0.8× 367 1.1× 194 1.1× 82 0.7× 43 0.5× 9 622
Cuiju Tang China 14 340 0.9× 382 1.2× 178 1.0× 240 2.0× 34 0.4× 47 853

Countries citing papers authored by Igor Bado

Since Specialization
Citations

This map shows the geographic impact of Igor Bado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Bado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Bado more than expected).

Fields of papers citing papers by Igor Bado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Bado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Bado. The network helps show where Igor Bado may publish in the future.

Co-authorship network of co-authors of Igor Bado

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Bado. A scholar is included among the top collaborators of Igor Bado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Bado. Igor Bado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Darbandi, Mahsa, et al.. (2024). Artificial intelligence breakthroughs in pioneering early diagnosis and precision treatment of breast cancer: A multimethod study. European Journal of Cancer. 209. 114227–114227. 19 indexed citations
2.
Darbandi, Mahsa & Igor Bado. (2024). Tumor Microenvironment and Epigenetic Implications in Breast Cancer Progression. Advances in experimental medicine and biology. 1465. 15–36. 1 indexed citations
3.
Bado, Igor, et al.. (2022). Review old bone, new tricks. Clinical & Experimental Metastasis. 39(5). 727–742. 4 indexed citations
4.
Bado, Igor, Martha Carlson, Isaac S. Chan, et al.. (2022). Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research. npj Breast Cancer. 8(1). 75–75. 2 indexed citations
5.
Tian, Zeru, Ling Wu, Chenfei Yu, et al.. (2021). Harnessing the power of antibodies to fight bone metastasis. Science Advances. 7(26). 30 indexed citations
6.
Zhang, Weijie, et al.. (2019). Bone Metastasis: Find Your Niche and Fit in. Trends in cancer. 5(2). 95–110. 70 indexed citations
7.
Gao, Yang, Igor Bado, Hai Wang, et al.. (2019). Metastasis Organotropism: Redefining the Congenial Soil. Developmental Cell. 49(3). 375–391. 259 indexed citations breakdown →
8.
Zhang, Weijie, et al.. (2019). Bone Tropism in Cancer Metastases. Cold Spring Harbor Perspectives in Medicine. 10(10). a036848–a036848. 16 indexed citations
9.
Wang, Hai, Lin Tian, Jun Liu, et al.. (2018). The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability. Cancer Cell. 34(5). 823–839.e7. 102 indexed citations
10.
Bado, Igor, et al.. (2018). ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function. Oncotarget. 9(32). 22509–22522. 17 indexed citations
11.
Nikolos, Fotis, Christoforos Thomas, Igor Bado, & Jan-Ακε Gustafsson. (2017). ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response. Molecular Cancer Research. 16(2). 233–242. 16 indexed citations
12.
Bado, Igor, Fotis Nikolos, Wanfu Wu, et al.. (2017). Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis. Breast Cancer Research. 19(1). 79–79. 20 indexed citations
13.
Bado, Igor, et al.. (2017). Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis. Oncogene. 36(32). 4527–4537. 37 indexed citations
14.
Bado, Igor, et al.. (2016). ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function. Oncotarget. 7(12). 13599–13611. 37 indexed citations
15.
Nikolos, Fotis, et al.. (2014). ERβ Regulates NSCLC Phenotypes by Controlling Oncogenic RAS Signaling. Molecular Cancer Research. 12(6). 843–854. 16 indexed citations
16.
Nikolos, Fotis, et al.. (2014). ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway. Oncogene. 34(31). 4130–4141. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026